Journal of Physiology and Biochemistry

, Volume 74, Issue 4, pp 635–646 | Cite as

Agaricus bisporus supplementation reduces high-fat diet-induced body weight gain and fatty liver development

  • María Iñiguez
  • Patricia Pérez-MatuteEmail author
  • María Jesús Villanueva-Millán
  • Emma Recio-Fernández
  • Irene Roncero-Ramos
  • Margarita Pérez-Clavijo
  • José-Antonio Oteo
Original Article


Obesity is a global epidemic characterized not only by excessive fat deposition but also by important complications such as nonalcoholic liver steatosis. Beneficial antiobesogenic effects have been described for some mushrooms. The current study aimed to demonstrate the protective effect of Agaricus bisporus (AB) supplementation against the metabolic alterations induced by high-fat-diet (HFD) feeding. Eight-week-old C57BL/6J mice were fed for 10 weeks with one of the following diets: (1) control diet (n = 7), (2) HFD (n = 7), (3) HFD supplemented with 5% AB (n = 9), and (4) HFD supplemented with 10% AB (n = 9). A pair-fed group was also included for the 10% AB group (n = 6). The impact of AB supplementation on food intake, body weight gain, and liver and fat pad weights was examined. Biochemical, histological, and molecular parameters were also analyzed. Dietary supplementation with 10% AB reduced the HFD-induced increase in body, epididymal, and mesenteric fat weights (p < 0.01, p < 0.05, and p < 0.05, respectively). Supplementation with AB also reduced liver damage in a dose-dependent manner (p < 0.01 and p < 0.001). This effect was confirmed by histological analysis that showed that liver steatosis was markedly reduced in mice fed with AB. The beneficial properties of 10% AB supplementation appear to be mediated through a decrease in food intake and via stimulation of mesenteric and hepatic free-fatty acid beta-oxidation, along with a decrease in epidydimal and hepatic expression of CD36. In conclusion, supplementation with AB prevents excessive body weight gain and liver steatosis induced by HFD consumption.


Agricus bisporus Liver steatosis High-fat diet-induced obesity 



We appreciate the excellent technical assistance of Judith Narro and the helpful advice from Dr. Alfredo Martinez in the histology analysis.

Funding information

This work was supported by a grant from the Agencia de Desarrollo Económico de La Rioja (ADER) (project number 2014-I-IDD-00091). ADER played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Compliance with ethical standards

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures involving animals were in accordance with the ethical standards of the ethics committee on animal welfare of our institution (Comité Ético de Experimentación Animal del Centro de Investigación Biomédica de La Rioja, CEEA-CIBIR).


  1. 1.
    Alam N, Amin R, Khan A, Ara I, Shim MJ, Lee MW, Lee UY, Lee TS (2009) Comparative effects of oyster mushrooms on lipid profile, liver and kidney function in hypercholesterolemic rats. Mycobiology 37(1):37–42. CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Anandhi R, Annadurai T, Anitha TS, Muralidharan AR, Najmunnisha K, Nachiappan V, Thomas PA, Geraldine P (2013) Antihypercholesterolemic and antioxidative effects of an extract of the oyster mushroom, Pleurotus ostreatus, and its major constituent, chrysin, in triton WR-1339-induced hypercholesterolemic rats. J Physiol Biochem 69(2):313–323. CrossRefPubMedGoogle Scholar
  3. 3.
    Andersson T, Simonyte K, Andrew R, Strand M, Burén J, Walker BR, Mattsson C, Olsson T (2009) Tissue-specific increases in 11beta-hydroxysteroid dehydrogenase type 1 in normal weight postmenopausal women. PLoS One 4(12):e8475. CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bahadoran Z, Tohidi M, Nazeri P, Mehran M, Azizi F, Mirmiran P (2012) Effect of broccoli sprouts on insulin resistance in type 2 diabetic patients: a randomized double-blind clinical trial. Int J Food Sci Nutr 63(7):767–771. CrossRefPubMedGoogle Scholar
  5. 5.
    Beck EJ, Tosh SM, Batterham MJ, Tapsell LC, Huang XF (2009) Oat beta-glucan increases postprandial cholecystokinin levels, decreases insulin response and extends subjective satiety in overweight subjects. Mol Nutr Food Res 53(10):1343–1351. CrossRefPubMedGoogle Scholar
  6. 6.
    Bonen A, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ (2006) The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes. Int J Obes (Lond) 30(6):877–883. CrossRefGoogle Scholar
  7. 7.
    Bray GA, Paeratakul S, Popkin BM (2004) Dietary fat and obesity: a review of animal, clinical and epidemiological studies. Physiol Behav 83(4):549–555. CrossRefPubMedGoogle Scholar
  8. 8.
    Brennan CS (2005) Dietary fibre, glycaemic response, and diabetes. Mol Nutr Food Res 49(6):560–570. CrossRefPubMedGoogle Scholar
  9. 9.
    Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94(9):2467–2474. CrossRefPubMedGoogle Scholar
  10. 10.
    Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M (2002) Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123(1):134–140CrossRefGoogle Scholar
  11. 11.
    Caesar R, Manieri M, Kelder T, Boekschoten M, Evelo C, Muller M, Kooistra T, Cinti S, Kleemann R, Drevon CA (2010) A combined transcriptomics and lipidomics analysis of subcutaneous, epididymal and mesenteric adipose tissue reveals marked functional differences. PLoS One 5(7):e11525. CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Chen S, Oh SR, Phung S, Hur G, Ye JJ, Kwok SL, Shrode GE, Belury M, Adams LS, Williams D (2006) Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus). Cancer Res 66(24):12026–12034. CrossRefPubMedGoogle Scholar
  13. 13.
    Chusyd DE, Wang D, Huffman DM, Nagy TR (2016) Relationships between rodent white adipose fat pads and human white adipose fat depots. Front Nutr 3:10. CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    de Miranda AM, Ribeiro GM, Cunha AC, Silva LS, dos Santos RC, Pedrosa ML, Silva ME (2014) Hypolipidemic effect of the edible mushroom Agaricus blazei in rats subjected to a hypercholesterolemic diet. J Physiol Biochem 70(1):215–224. CrossRefPubMedGoogle Scholar
  15. 15.
    Delargy HJ, O’Sullivan KR, Fletcher RJ, Blundell JE (1997) Effects of amount and type of dietary fibre (soluble and insoluble) on short-term control of appetite. Int J Food Sci Nutr 48(1):67–77CrossRefGoogle Scholar
  16. 16.
    Dixon JB, Bhathal PS, O’Brien PE (2001) Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121(1):91–100CrossRefGoogle Scholar
  17. 17.
    Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115(5):1343–1351. CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Drapeau V, King N, Hetherington M, Doucet E, Blundell J, Tremblay A (2007) Appetite sensations and satiety quotient: predictors of energy intake and weight loss. Appetite 48(2):159–166. CrossRefPubMedGoogle Scholar
  19. 19.
    Dubost NJ, Ou B, Beelman RB (2007) Quantification of polyphenols and ergothioneine in cultivated mushrooms and correlation to total antioxidant capacity. Food Chem 105:727–735. CrossRefGoogle Scholar
  20. 20.
    Fernandez-Galilea M, Perez-Matute P, Prieto-Hontoria PL, Martinez JA, Moreno-Aliaga MJ (2012) Effects of lipoic acid on lipolysis in 3T3-L1 adipocytes. J Lipid Res 53(11):2296–2306. CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D’Agostino RB Sr, O’Donnell CJ (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation 116(1):39–48. CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Granneman JG, Moore HP, Krishnamoorthy R, Rathod M (2009) Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl). J Biol Chem 284(50):34538–34544. CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Hajri T, Hall AM, Jensen DR, Pietka TA, Drover VA, Tao H, Eckel R, Abumrad NA (2007) CD36-facilitated fatty acid uptake inhibits leptin production and signaling in adipose tissue. Diabetes 56(7):1872–1880. CrossRefPubMedGoogle Scholar
  24. 24.
    Handayani D, Chen J, Meyer BJ, Huang XF (2011) Dietary shiitake mushroom (Lentinus edodes) prevents fat deposition and lowers triglyceride in rats fed a high-fat diet. J Obes 2011:258051. CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK, Rao MS (2000) Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem 275(37):28918–28928. CrossRefPubMedGoogle Scholar
  26. 26.
    Hocking SL, Chisholm DJ, James DE (2008) Studies of regional adipose transplantation reveal a unique and beneficial interaction between subcutaneous adipose tissue and the intra-abdominal compartment. Diabetologia 51(5):900–902. CrossRefPubMedGoogle Scholar
  27. 27.
    Hruby A, Hu FB (2015) The epidemiology of obesity: a big picture. PharmacoEconomics 33(7):673–689. CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Huang J, Ou Y, Yew TWD, Liu J, Leng B, Lin Z, Su Y, Zhuang Y, Lin J, Li X, Xue Y, Pan Y (2016) Hepatoprotective effects of polysaccharide isolated from Agaricus bisporus industrial wastewater against CCl4-induced hepatic injury in mice. Int J Biol Macromol 82:678–686. CrossRefPubMedGoogle Scholar
  29. 29.
    Hughes K (2002) Chitosan and dietary fibers. Prepared Foods. NS11-NS14Google Scholar
  30. 30.
    Jayakumar T, Ramesh E, Geraldine P (2006) Antioxidant activity of the oyster mushroom, Pleurotus ostreatus, on CCl(4)-induced liver injury in rats. Food Chem Toxicol 44(12):1989–1996. CrossRefPubMedGoogle Scholar
  31. 31.
    Jeong SC, Jeong YT, Yang BK, Islam R, Koyyalamudi SR, Pang G, Cho KY, Song CH (2010) White button mushroom (Agaricus bisporus) lowers blood glucose and cholesterol levels in diabetic and hypercholesterolemic rats. Nutr Res 30(1):49–56. CrossRefPubMedGoogle Scholar
  32. 32.
    Jo Feeney M, Miller AM, Roupas P (2014) Mushrooms-biologically distinct and nutritionally unique. Exploring a “Third Food Kingdom” Nutr Today 49(6):301–307. CrossRefPubMedGoogle Scholar
  33. 33.
    Kabir Y, Kimura S (1989) Dietary mushrooms reduce blood pressure in spontaneously hypertensive rats (SHR). J Nutr Sci Vitaminol (Tokyo) 35(1):91–94CrossRefGoogle Scholar
  34. 34.
    Kanaya N, Kubo M, Liu Z, Chu P, Wang C, Yuan YC, Chen S (2011) Protective effects of white button mushroom (Agaricus bisporus) against hepatic steatosis in ovariectomized mice as a model of postmenopausal women. PLoS One 6(10):e26654. CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC, Disease PPCotAAftSoL (2008) Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47(4):1363–1370. CrossRefPubMedGoogle Scholar
  36. 36.
    Koo SH (2013) Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis. Clin Mol Hepatol 19(3):210–215. CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Koyyalamudi SR, Jeong SC, Song CH, Cho KY, Pang G (2009) Vitamin D2 formation and bioavailability from Agaricus bisporus button mushrooms treated with ultraviolet irradiation. J Agric Food Chem 57(8):3351–3355. CrossRefPubMedGoogle Scholar
  38. 38.
    Kozarski M, Klaus A, Niksic M, Jakovljevic D, Helsper J, VG L (2011) Antioxidative and immunomodulating activities of polysaccharide extracts of the medicinal mushrooms Agaricus bisporus, Agaricus brasiliensis, Ganoderma lucidum and Phellinus linteus. Food Chem 129(4):1667–1675. CrossRefGoogle Scholar
  39. 39.
    Leone TC, Weinheimer CJ, Kelly DP (1999) A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 96(13):7473–7478CrossRefGoogle Scholar
  40. 40.
    Liu KH, Chan YL, Chan JC, Chan WB, Kong WL (2006) Mesenteric fat thickness as an independent determinant of fatty liver. Int J Obes 30(5):787–793. CrossRefGoogle Scholar
  41. 41.
    Liu J, Jia L, Kan J, Jin CH (2013) In vitro and in vivo antioxidant activity of ethanolic extract of white button mushroom (Agaricus bisporus). Food Chem Toxicol 51:310–316. CrossRefPubMedGoogle Scholar
  42. 42.
    Lodhi IJ, Yin L, Jensen-Urstad AP, Funai K, Coleman T, Baird JH, El Ramahi MK, Razani B, Song H, Fu-Hsu F, Turk J, Semenkovich CF (2012) Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARgamma activation to decrease diet-induced obesity. Cell Metab 16(2):189–201. CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Lomba A, Martinez JA, Garcia-Diaz DF, Paternain L, Marti A, Campion J, Milagro FI (2010) Weight gain induced by an isocaloric pair-fed high fat diet: a nutriepigenetic study on FASN and NDUFB6 gene promoters. Mol Genet Metab 101(2–3):273–278. CrossRefPubMedGoogle Scholar
  44. 44.
    Londos C, Brasaemle DL, Schultz CJ, Adler-Wailes DC, Levin DM, Kimmel AR, Rondinone CM (1999) On the control of lipolysis in adipocytes. Ann N Y Acad Sci 892:155–168CrossRefGoogle Scholar
  45. 45.
    Maffetone PB, Rivera-Dominguez I, Laursen PB (2017) Overfat adults and children in developed countries: the public health importance of identifying excess body fat. Front Public Health 5:190. CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Michelotti GA, Machado MV, Diehl AM (2013) NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol 10(11):656–665. CrossRefPubMedGoogle Scholar
  47. 47.
    Miyoshi H, Souza SC, Zhang HH, Strissel KJ, Christoffolete MA, Kovsan J, Rudich A, Kraemer FB, Bianco AC, Obin MS, Greenberg AS (2006) Perilipin promotes hormone-sensitive lipase-mediated adipocyte lipolysis via phosphorylation-dependent and -independent mechanisms. J Biol Chem 281(23):15837–15844. CrossRefPubMedGoogle Scholar
  48. 48.
    Miyoshi H, Perfield JW 2nd, Obin MS, Greenberg AS (2008) Adipose triglyceride lipase regulates basal lipolysis and lipid droplet size in adipocytes. J Cell Biochem 105(6):1430–1436. CrossRefGoogle Scholar
  49. 49.
    Moro C, Palacios I, Lozano M, D’Arrigo M, Guillamón E, Villares A, Martinez A, García-Lafuente A (2012) Anti-inflammatory activity of methanolic extracts from edible mushrooms in LPS activated RAW 264.7 macrophages. Food Chem 130:350–355. CrossRefGoogle Scholar
  50. 50.
    Palou M, Sanchez J, Priego T, Rodriguez AM, Pico C, Palou A (2010) Regional differences in the expression of genes involved in lipid metabolism in adipose tissue in response to short- and medium-term fasting and refeeding. J Nutr Biochem 21(1):23–33. CrossRefPubMedGoogle Scholar
  51. 51.
    Park CW, Zhang Y, Zhang X, Wu J, Chen L, Cha DR, Su D, Hwang MT, Fan X, Davis L, Striker G, Zheng F, Breyer M, Guan Y (2006) PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice. Kidney Int 69(9):1511–1517. CrossRefPubMedGoogle Scholar
  52. 52.
    Park MK, Han Y, Kim MS, Seo E, Kang S, Park SY, Koh H, Kim DK, Lee HJ (2012) Reduction of food intake by Fenofibrate is associated with cholecystokinin release in long-Evans Tokushima rats. Korean J Physiol Pharmacol 16(3):181–186. CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Perez-Matute P, Neville MJ, Tan GD, Frayn KN, Karpe F (2009) Transcriptional control of human adipose tissue blood flow. Obesity 17(4):681–688. CrossRefPubMedGoogle Scholar
  54. 54.
    Rakhshandehroo M, Knoch B, Muller M, Kersten S (2010) Peroxisome proliferator-activated receptor alpha target genes. PPAR Res 2010:1–20. CrossRefGoogle Scholar
  55. 55.
    Saggerson D (2008) Malonyl-CoA, a key signaling molecule in mammalian cells. Annu Rev Nutr 28:253–272. CrossRefPubMedGoogle Scholar
  56. 56.
    Saito N, Kimura S, Miyamoto T, Fukushima S, Amagasa M, Shimamoto Y, Nishioka C, Okamoto S, Toda C, Washio K, Asano A, Miyoshi I, Takahashi E, Kitamura H (2017) Macrophage ubiquitin-specific protease 2 modifies insulin sensitivity in obese mice. Biochem Biophys Rep 9:322–329. CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Sattar N, Forrest E, Preiss D (2014) Non-alcoholic fatty liver disease. BMJ 349:g4596. CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Slavin J, Green H (2007) Dietary fibre and satiety. Nutr Bull 32(s1):32–42. CrossRefGoogle Scholar
  59. 59.
    Theuwissen E, Mensink RP (2008) Water-soluble dietary fibers and cardiovascular disease. Physiol Behav 94(2):285–292. CrossRefPubMedGoogle Scholar
  60. 60.
    Valdecantos MP, Perez-Matute P, Gonzalez-Muniesa P, Prieto-Hontoria PL, Moreno-Aliaga MJ, Martinez JA (2012) Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function. J Nutr Biochem 23(12):1676–1684. CrossRefPubMedGoogle Scholar
  61. 61.
    Willis HJ, Eldridge AL, Beiseigel J, Thomas W, Slavin JL (2009) Greater satiety response with resistant starch and corn bran in human subjects. Nutr Res 29(2):100–105. CrossRefPubMedGoogle Scholar
  62. 62.
    Wilson CG, Tran JL, Erion DM, Vera NB, Febbraio M, Weiss EJ (2016) Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice. Endocrinology 157(2):570–585. CrossRefPubMedGoogle Scholar
  63. 63.
    Wueest S, Item F, Lucchini FC, Challa TD, Muller W, Bluher M, Konrad D (2016) Mesenteric fat lipolysis mediates obesity-associated hepatic steatosis and insulin resistance. Diabetes 65(1):140–148. CrossRefPubMedGoogle Scholar

Copyright information

© University of Navarra 2018

Authors and Affiliations

  • María Iñiguez
    • 1
  • Patricia Pérez-Matute
    • 1
    Email author
  • María Jesús Villanueva-Millán
    • 1
  • Emma Recio-Fernández
    • 1
  • Irene Roncero-Ramos
    • 2
  • Margarita Pérez-Clavijo
    • 2
  • José-Antonio Oteo
    • 1
    • 3
  1. 1.Infectious Diseases, Microbiota and Metabolism Unit, Infectious Diseases Department, Center for Biomedical Research of La Rioja (CIBIR)LogroñoSpain
  2. 2.Mushroom Technological Research Center of La Rioja (CTICH)AutolSpain
  3. 3.Infectious Diseases DepartmentHospital San PedroLogroñoSpain

Personalised recommendations